Determining the necessity of phenyl ring π-character in warfarin.

导出 OA

翻译打印收藏纠错

第一作者： Hui,Xing

第一单位： School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane 4072, Queensland, Australia.

作者： Hui,Xing ^[1] ; Sevan D,Houston ^[1] ; Xuejie,Chen ^[2] ; Da-Yun,Jin ^[2] ; G Paul,Savage ^[3] ; Jian-Ke,Tie ^[2] ; Craig M,Williams ^[4]

作者单位： School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane 4072, Queensland, Australia. ^[1] Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ^[2] CSIRO Manufacturing, Ian Wark Laboratory, Melbourne 3168, Victoria, Australia. ^[3] School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane 4072, Queensland, Australia. Electronic address: c.williams3@uq.edu.au. ^[4]

关键词 Cyclohexane Cyclooctane VKOR Warfarin π-Interaction

主题词抗凝药(Anticoagulants);人类(Humans);华法林(Warfarin)

DOI 10.1016/j.bmcl.2019.05.039

PMID 31147103

发布时间 2021-02-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交